International Journal of Nanomaterials and Nanostructures
Nanostructures: Advancing Targeted Metabolic Engineering for Treating Metabolic Disorders.
Abstract
Nanostructures have emerged as powerful tools in the field of targeted metabolic engineering,offering precise control over metabolic pathways in specific cells or tissues. This technologyholds great promise for treating a wide range of metabolic disorders by modulating cellularmetabolism at the nanoscale.One of the key advantages of nanostructures in metabolic engineering is their ability to targetspecific cells or tissues with high precision. By encapsulating or delivering metabolicmodulators such as enzymes, cofactors, or small molecules, nanostructures can effectivelyregulate metabolic pathways in a spatially and temporally controlled manner. This targetedapproach minimizes off-target effects and enhances the effectiveness of treatment.Nanostructures also offer advantages in terms of stability and bioavailability of metabolicmodulators. By protecting these molecules from degradation and enhancing their uptake bytarget cells, nanostructures can improve the overall efficacy of metabolic engineeringstrategies. Additionally, nanostructures can be engineered to respond to specific stimuli, suchas changes in pH or enzyme activity, further enhancing their precision and control overmetabolic pathways.In the context of treating metabolic disorders, nanostructures show promise in addressingconditions such as diabetes, obesity, and metabolic syndrome. For example, nanostructurescan be used to deliver insulin or other glucose-regulating molecules directly to pancreaticcells, improving glucose metabolism and reducing the risk of complications associated withdiabetes.Nanostructures represent a promising avenue for advancing targeted metabolic engineeringand treating metabolic disorders. Future research in this field is likely to focus on optimizingnanostructure design, improving their specificity and efficacy, and exploring new applicationsfor treating a variety of metabolic conditions.Keywords
References (41)
- Ai X, Wang S, Duan Y, Zhang Q, Chen MS, Gao W, Zhang L. Emerging approaches to
- functionalizing cell membrane-coated nanoparticles. Biochemistry. 2020 May 26;60(13):941-
- Elgogary A, Xu Q, Poore B, Alt J, Zimmermann SC, Zhao L, Fu J, Chen B, Xia S, Liu Y,
- Neisser M. Combination therapy with BPTES nanoparticles and metformin targets the
- metabolic heterogeneity of pancreatic cancer. Proceedings of the National Academy of
- Sciences. 2016 Sep 6;113(36):E5328-36.
- Satapathy MK, Yen TL, Jan JS, Tang RD, Wang JY, Taliyan R, Yang CH. Solid lipid
- nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB.
- Pharmaceutics. 2021 Jul 31;13(8):1183.
- Arya SS, Rookes JE, Cahill DM, Lenka SK. Next-generation metabolic engineering
- approaches towards development of plant cell suspension cultures as specialized metabolite
- producing biofactories. Biotechnology Advances. 2020 Dec 1;45:107635.
- Sun F, Zhu Q, Li T, Saeed M, Xu Z, Zhong F, Song R, Huai M, Zheng M, Xie C, Xu L.
- Regulating glucose metabolism with prodrug nanoparticles for promoting
- photoimmunotherapy of pancreatic cancer. Advanced Science. 2021 Feb;8(4):2002746.
- Dangi AK, Sharma B, Hill RT, Shukla P. Bioremediation through microbes: systems
- biology and metabolic engineering approach. Critical reviews in biotechnology. 2019 Jan
- Dudley QM, Karim AS, Jewett MC. Cell‐free metabolic engineering: biomanufacturing
- beyond the cell. Biotechnology journal. 2015 Jan;10(1):69-82.
- Kumar A, Zhang X, Liang XJ. Gold nanoparticles: emerging paradigm for targeted drug
- delivery system. Biotechnology advances. 2013 Sep 1;31(5):593-606.
- des Rieux A, Pourcelle V, Cani PD, Marchand-Brynaert J, Préat V. Targeted nanoparticles
- with novel non-peptidic ligands for oral delivery. Advanced drug delivery reviews. 2013 Jun
- Liu WS, Liu Y, Gao J, Zheng H, Lu ZM, Li M. Biomembrane-Based Nanostructure-and
- Microstructure-Loaded Hydrogels for Promoting Chronic Wound Healing. International
- Journal of Nanomedicine. 2023 Dec 31:385-411.
- Villa CH, Anselmo AC, Mitragotri S, Muzykantov V. Red blood cells: Supercarriers for
- drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
- Advanced drug delivery reviews. 2016 Nov 15;106:88-103.
- Feng Y, Liao Z, Li M, Zhang H, Li T, Qin X, Li S, Wu C, You F, Liao X, Cai L.
- Mesoporous silica nanoparticles‐based nanoplatforms: basic construction, current state, and
- emerging applications in anticancer therapeutics. Advanced Healthcare Materials. 2023
- Jun;12(16):2201884.
- Mao D, Hu F, Kenry, Ji S, Wu W, Ding D, Kong D, Liu B.
- Metal–organic‐framework‐assisted in vivo bacterial metabolic labeling and precise
- antibacterial therapy. Advanced materials. 2018 May;30(18):1706831.
- Klumbys E, Zebec Z, Weise NJ, Turner NJ, Scrutton NS. Bio-derived production of
- cinnamyl alcohol via a three step biocatalytic cascade and metabolic engineering. Green
- Chemistry. 2018;20(3):658-63.
- Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery.
- Advanced drug delivery reviews. 2008 Aug 17;60(11):1252-65.